Britten Gordon, BS

Graduate Research Associate
The Ohio State University

My name is Britten Gordon (BS) and I am currently a PhD Candidate under Dr. Jennifer Woyach at The Ohio State University. I conduct research on novel therapeutic strategies for treating Chronic Lymphocytic Leukemia (CLL) and resistance mechanisms to small molecule inhibitors. We are primarily focused on perofmring pre-clinical studies on these inhibitors and assessing their efficacy in both naive and resistant CLL.

Poster(s):

• 1004 - The PKCβ inhibitor MS-553 displays preclinical efficacy in BTK inhibitor resistant Chronic Lymphocytic Leukemia

• 1120 - Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T cell phenotypes in CLL patients treated with ibrutinib.